3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Specimen Handling
63
Magnetic Resonance Spectroscopy
43
Carboplatin
34
Cyclophosphamide
31
Gemcitabine
29
Cisplatin
27
Biopsy
27
pembrolizumab
26
Radiotherapy
26
Bevacizumab
25
Paclitaxel
23
Oxaliplatin
22
Capecitabine
22
venetoclax
21
Standard of Care
21
Injections
21
Drug Therapy
21
fludarabine
20
Nivolumab
20
Interviews as Topic
18
toripalimab
17
Radiosurgery
16
Dexamethasone
16
Blood Specimen Collection
16
Azacitidine
16
tislelizumab
14
cemiplimab
13
anlotinib
13
Irinotecan
13
130-nm albumin-bound paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
90 days
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled